CASGEVY Gets Bahrain approval for treatment, marking it second country in the world
MANAMA, Bahrain, Dec. 02, 2023 (GLOBE NEWSWIRE) -- Bahrain has become the second country in the world and the first...
Pharmaceutical
Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023)
VANCOUVER, British Columbia, Dec. 02, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced it...
Junshi Biosciences Announces New Chemical Entity Application for Toripalimab Accepted by Australia’s TGA
SHANGHAI, China, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a...
BioHarvest Sciences to Host Virtual Shareholder Update December 13, 2023, 2:30pm ET
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 1, 2023) - BioHarvest Sciences Inc. ("BioHarvest" or the "Company") (CSE:...
Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product
CHICAGO, IL / ACCESSWIRE / December 1, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
iZafe Group Board Member Bosse Johansson Purchases 800,000 Shares
STOCKHOLM, SWEDEN / ACCESSWIRE / December 01, 2023 / iZafe Group (STO:IZAFE-B) iZafe Group's board member, Bosse Johansson, acquired 800,000...
Pressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray – MMA Champ Cat Zingano Now Official VST Ambassador
Initial Revenue Expected to Reach $1.0 Million in Year 1 Increasing to More Than $10 Million in Year 5 of...
NLS Pharmaceutics Announces Exclusive Option Agreement to Develop and Commercialize Next Generation Dual Orexin Agonist Platform of Aexon Labs, Inc.
The option agreement grants NLS Pharmaceutics Ltd. the exclusive option to in-license all of Aexon Labs' assets for the potential...
Regeneron to Host Investor Call and Webcast on December 14, 2023 to Provide Updates Across Its Hematology Portfolio
TARRYTOWN, N.Y., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will host a conference call and simultaneous...
Reviva Pharmaceuticals to Participate in The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
CUPERTINO, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage...
iZafe Group presented at Stora Aktiedagarna
STOCKHOLM, SWEDEN / ACCESSWIRE / November 30, 2023 / iZafe Group (STO:IZAFE-B) iZafe Group's CEO, Anders Segerström, presented the company...
FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement
TORONTO, ON / ACCESSWIRE / November 30, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company) and Celly...
Jaguar Health to Present December 5 at the MedInvest Oncology Investor Conference
Top line data for Jaguar Health's pivotal phase 3 OnTarget trial of crofelemer for prophylaxis of diarrhea in adult cancer...
Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023
Webcasted presentation to take place at 1:10pm ETDENVER, CO / ACCESSWIRE / November 30, 2023 / Aytu BioPharma, Inc. (the...
Poolbeg Pharma PLC Announces Directorate Change
LONDON, UK / ACCESSWIRE / November 30, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF, 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed...
Theralase Release’s 3Q2023 Interim Financial Statements
TORONTO, ON / ACCESSWIRE / November 29, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Theralase(R) Closes $CAN 1.17 Million Non-Brokered Private Placement
TORONTO, ON / ACCESSWIRE / November 29, 2023 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
CORRECTION BY SOURCE: Notice of Extraordinary General Meeting in Promore Pharma AB (Publ)
Addition after section "Proposed AGENDA"STOCKHOLM, SE / ACCESSWIRE / November 29, 2023 / Promore Pharma (STO:PROMO)(FRA:8T0)The shareholders of Promore Pharma...
Notice of Extraordinary General Meeting in Promore Pharma AB (Publ)
STOCKHOLM, SE / ACCESSWIRE / November 29, 2023 / Promore Pharma (STO:PROMO)(FRA:8T0)The shareholders of Promore Pharma AB (publ), reg. no....
GE HealthCare Highlights Commitment to Delivering Better Patient Experiences and Outcomes Through Deep Learning at RSNA 2023
GE HealthCare is proud to announce the addition of True Enhance DL to its Effortless Recon DL portfolioCHICAGO--(BUSINESS WIRE)--Through its...